Arcutis appoints Keith Leonard as Class I director; Ricky Sun resigns without disagreement

Arcutis Biotherapeutics, Inc.

Keith R. Leonard Jr. appointed Class I director, term expiring at 2024 annual meeting, effective Sept 2.
Ricky Sun resigned from Board effective Sept 2; no disagreement with company operations or policies.
Leonard joins Compensation Committee; receives 32,907-share stock option (3-year annual vest).
Annual cash retainer of $40,000 for Board service plus $7,500 for Compensation Committee membership.
Leonard to enter standard indemnification agreement with Arcutis.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Keith R. Leonard Jr.

Class I director

ARQT · Arcutis Biotherapeutics, Inc.

Effective: 2021-09-02
Filed: September 7, 2021, 7:59 PM ET

On September 2, 2021, the Board of Directors (the “Board”) of Arcutis Biotherapeutics, Inc. (the “Company” or “Arcutis”) appointed Keith R. Leonard Jr. as a Class I director with a term expiring at the Company’s 2024 Annual Meeting of Stockholders.

Departed

Ricky Sun

Director

ARQT · Arcutis Biotherapeutics, Inc.

Effective: 2021-09-02
Successor: Keith R. Leonard Jr.
Filed: September 7, 2021, 7:59 PM ET

Mr. Leonard fills the vacancy created by the resignation of Ricky Sun, Ph.D. who resigned from the Board effective September 2, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Keith R. Leonard Jr. was appointed as Class I director at Arcutis Biotherapeutics, Inc..

Action: appointed
Role: Class I director

Exact text from the filing

On September 2, 2021, the Board of Directors (the “Board”) of Arcutis Biotherapeutics, Inc. (the “Company” or “Arcutis”) appointed Keith R. Leonard Jr. as a Class I director with a term expiring at the Company’s 2024 Annual Meeting of Stockholders.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Ricky Sun resigned as Director at Arcutis Biotherapeutics, Inc..

Action: resigned
Role: Director

Exact text from the filing

Mr. Leonard fills the vacancy created by the resignation of Ricky Sun, Ph.D. who resigned from the Board effective September 2, 2021.

View on SEC.gov

Arcutis Biotherapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001787306-21-000013

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.